Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 51(10): 3642-9, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17682103

RESUMO

In this study we investigated the interplay of antibiotic pharmacokinetic profiles and the development of mutation-mediated resistance in wild-type and hypermutable Pseudomonas aeruginosa strains. We used in vitro models simulating profiles of the commonly used therapeutic drugs meropenem and ceftazidime, two agents with high levels of antipseudomonal activity said to have different potentials for stimulating resistance development. During ceftazidime treatment of the wild-type strain (PAO1), fully resistant mutants overproducing AmpC were selected rapidly and they completely replaced wild-type cells in the population. During treatment with meropenem, mutants of PAO1 were not selected as rapidly and showed only intermediate resistance due to the loss of OprD. These mutants also replaced the parent strain in the population. During the treatment of the mutator P. aeruginosa strain with meropenem, the slowly selected mutants did not accumulate several resistance mechanisms but only lost OprD and did not completely replace the parent strain in the population. Our results indicate that the commonly used dosing regimens for meropenem and ceftazidime cannot avoid the selection of mutants of wild-type and hypermutable P. aeruginosa strains. For the treatment outcome, including the prevention of resistance development, it would be beneficial for the antibiotic concentration to remain above the mutant prevention concentration for a longer period of time than it does in present regimens.


Assuntos
Antibacterianos/farmacologia , Ceftazidima/farmacologia , Farmacorresistência Bacteriana/genética , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/genética , Tienamicinas/farmacologia , Antibacterianos/farmacocinética , Ceftazidima/farmacocinética , Contagem de Colônia Microbiana , DNA Bacteriano/genética , Farmacorresistência Bacteriana Múltipla/genética , Inibidores Enzimáticos/farmacologia , Genótipo , Humanos , Masculino , Meropeném , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Mutação/genética , Fenótipo , Porinas/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tienamicinas/farmacocinética , Inibidores de beta-Lactamases
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...